Aarey Drugs & Pharmaceuticals vs Nifty 50: Returns Compared
- September 3, 2026
- Posted by: Kunal Singla
- Category: Market
Aarey Drugs & Pharmaceuticals share price Rs 91.72 on NSE. Aarey Drugs & Pharmaceuticals vs Nifty 50 over 1 year: +45.22% vs -2.41%. 52-week high Rs 100.00, low Rs 50.31.
Quick Answer
Aarey Drugs & Pharmaceuticals vs Nifty 50 shows Aarey Drugs & Pharmaceuticals ahead of the benchmark on a one-year view, gaining +45.22% against the Nifty 50’s -2.41%. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter’s swing. Investors comparing the two should also weigh Aarey Drugs & Pharmaceuticals’s trading liquidity, valuation and sector context rather than relying on returns alone.
Aarey Drugs & Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Aarey Drugs & Pharmaceuticals trades on the NSE under the symbol AAREYDRUGS, and its 1M return of +17.8% compares with the Nifty 50’s -1.44% over the same period.
The Aarey Drugs & Pharmaceuticals vs Nifty 50 comparison matters because Aarey Drugs & Pharmaceuticals is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Aarey Drugs & Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, 5 years, using NSE closing data.
Click Here – Get Free Investment Predictions
Aarey Drugs & Pharmaceuticals vs Nifty 50: Performance at a Glance
The table below sets out Aarey Drugs & Pharmaceuticals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 3 September 2026.
| Time Frame | Aarey Drugs & Pharmaceuticals Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | +17.8% | -1.44% | +19.24% pp |
| 3 Months | +18.55% | +2.78% | +15.77% pp |
| 6 Months | +31.65% | -3.35% | +35.0% pp |
| 1 Year | +45.22% | -2.41% | +47.63% pp |
| 3 Years | +91.08% | +23.65% | +67.43% pp |
| 5 Years | +141.37% (Aarey Drugs & Pharmaceuticals) | +40.73% (Nifty 50) | +100.64% pp |
On the Aarey Drugs & Pharmaceuticals vs Nifty 50 scorecard, Aarey Drugs & Pharmaceuticals has stayed ahead of the index over the most recent one-year window. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter’s swing.
Check the Univest Screener for live Aarey Drugs & Pharmaceuticals and Nifty 50 data
Why the Aarey Drugs & Pharmaceuticals vs Nifty 50 Gap Exists
Aarey Drugs & Pharmaceuticals’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Aarey Drugs & Pharmaceuticals vs Nifty 50 return table above.
A second factor behind the Aarey Drugs & Pharmaceuticals vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Aarey Drugs & Pharmaceuticals’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Aarey Drugs & Pharmaceuticals and Nifty 50 live on the go.
Aarey Drugs & Pharmaceuticals vs Nifty 50: Has Aarey Drugs & Pharmaceuticals Beaten the Benchmark?
Aarey Drugs & Pharmaceuticals has beaten the Nifty 50 over the past year, gaining +45.22% against the index’s -2.41% over the same period. Over the longer term the picture has stayed in the stock’s favour.
Risks of the Aarey Drugs & Pharmaceuticals vs Nifty 50 Comparison
Reading too much into a Aarey Drugs & Pharmaceuticals vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Aarey Drugs & Pharmaceuticals carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 50.31 to Rs 100.00 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Aarey Drugs & Pharmaceuticals vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Aarey Drugs & Pharmaceuticals vs Nifty 50 record should factor in Aarey Drugs & Pharmaceuticals’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Aarey Drugs & Pharmaceuticals outperformed the Nifty 50 in the last year?
Ans. Yes. Aarey Drugs & Pharmaceuticals gained +45.22% over the past year while the Nifty 50 returned -2.41% over the same period, based on NSE closing prices to 3 September 2026.
How does Aarey Drugs & Pharmaceuticals vs Nifty 50 look over 5 years?
Ans. Over five years Aarey Drugs & Pharmaceuticals has returned +141.37% compared with the Nifty 50’s +40.73%, so in the Aarey Drugs & Pharmaceuticals vs Nifty 50 comparison the stock has been ahead over this longer horizon.
What is the Aarey Drugs & Pharmaceuticals share price today compared to Nifty 50?
Ans. Aarey Drugs & Pharmaceuticals share price stood at Rs 91.72 on NSE, while the Nifty 50 traded at 24,031.60 based on the same closing data window.
What is the 52-week high and low of Aarey Drugs & Pharmaceuticals?
Ans. Aarey Drugs & Pharmaceuticals’s 52-week high is Rs 100.00 and its 52-week low is Rs 50.31, based on NSE data.
Why does Aarey Drugs & Pharmaceuticals show bigger price swings than the Nifty 50?
Ans. Aarey Drugs & Pharmaceuticals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Aarey Drugs & Pharmaceuticals’s price more sharply than the diversified index, a key reason the Aarey Drugs & Pharmaceuticals vs Nifty 50 return gap varies across time frames.
Is Aarey Drugs & Pharmaceuticals a good long-term investment compared to a Nifty 50 index fund?
Ans. Aarey Drugs & Pharmaceuticals’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Aarey Drugs & Pharmaceuticals vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
